Administration of neferine (5 mg/kg) for 3 weeks via gastrogavage has been reported to decrease fasting blood glucose, insulin, TG, and TNF-α and increase insulin sensitivity in insulin resistance-induced rats [44]. This evidence concerns the gene INS and Insulin resistance.